Home › Acute Myeloid Leukemia › California › Concord
Acute Myeloid Leukemia clinical trials in Concord, CA
3 studies for Acute Myeloid Leukemia are looking for participants at sites in and around Concord (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RecruitingPhase 2
- Kaiser Permanente-Walnut Creek, Walnut Creek · 5 mi away
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- John Muir Medical Center-Walnut Creek, Walnut Creek · 5 mi away
- Contra Costa Regional Medical Center, Martinez · 6 mi away
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Kaiser Permanente-Walnut Creek, Walnut Creek · 5 mi away
About Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML) is a cancer of the white blood cells. AML usually gets worse quickly if it is not treated. Read more.
More about Acute Myeloid Leukemia on MedlinePlus
Acute Myeloid Leukemia trials in other cities
- Houston, TX85 studies
- New York City, NY51 studies
- Boston, MA44 studies
- Seattle, WA41 studies
- Baldwin Park, CA40 studies
- Columbus, OH35 studies
- Philadelphia, PA34 studies
- Durham, NC33 studies
- Atlanta, GA31 studies
- Tampa, FL29 studies
- Chicago, IL26 studies
- Portland, OR25 studies
Other studies in Concord
- Obesity18 studies
- Overweight16 studies
- Non-Small Cell Lung Cancer14 studies
- Major Depressive Disorder12 studies
- Type 2 Diabetes10 studies
- Breast Cancer9 studies
- Lung Cancer9 studies
- Migraine8 studies
- Cancer (all types)7 studies
- Depression6 studies
- Prostate Cancer6 studies
- Diabetes5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.